Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug 28;24(1):526.
doi: 10.1186/s13054-020-03257-y.

Ketanserin as potential additive drug to improve V/Q mismatch in COVID-19?

M Kuindersma  1 , P E Spronk  2   3
Affiliations
Comment

Ketanserin as potential additive drug to improve V/Q mismatch in COVID-19?

M Kuindersma et al. Crit Care. .
No abstract available

Keywords: COVID-19; Coronavirus; Lung; V/Q mismatch; Vasoconstriction.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Comment on

References

    1. Santamarina MG, Boisier D, Contreras R, Baque M, Volpacchio M, Beddings I. COVID-19: a hypothesis regarding the ventilation-perfusion mismatch. Crit Care. 2020;24(1):395. doi: 10.1186/s13054-020-03125-9. - DOI - PMC - PubMed
    1. Vellinga NA, Veenstra G, Scorcella C, Koopmans M, van Roon EN, Ince C, et al. Effects of ketanserin on microcirculatory alterations in septic shock: an open-label pilot study. J Crit Care. 2015;30(6):1156–1162. doi: 10.1016/j.jcrc.2015.07.004. - DOI - PubMed
    1. Han TH, Qamirani E, Nelson AG, Hyduke DR, Chaudhuri G, Kuo L, et al. Regulation of nitric oxide consumption by hypoxic red blood cells. Proc Natl Acad Sci U S A. 2003;100(21):12504–12509. doi: 10.1073/pnas.2133409100. - DOI - PMC - PubMed
    1. Wu R, Wang L, Kuo HD, et al. An update on current therapeutic drugs treating COVID-19 [published online ahead of print, 2020 May 11]. Curr Pharmacol Rep. 2020;1–15. 10.1007/s40495-020-00216-7. - PMC - PubMed
    1. Meuleman TR, Hill DC, Port JD, Stanley TH, Pace NL, Mohammad SF. Ketanserin prevents platelet aggregation and endotoxin-induced pulmonary vasoconstriction. Crit Care Med. 1983;11(8):606–611. doi: 10.1097/00003246-198308000-00005. - DOI - PubMed

LinkOut - more resources